NCT02712125View on ClinicalTrials.gov

Nitric Oxide Donors for Treatment of Isolated Oligohydramnios

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions
Isolated (Idiopathic) Oligohydramnios
Interventions
DRUG

isosorbide mononitrate

20 mg isosorbide mononitrate (IMN) tablet applied vaginally once daily until delivery .

DRUG

Placebo

placebo vaginal tablets once daily until delivery

All Listed Sponsors
lead

Benha University

OTHER

NCT02712125 - Nitric Oxide Donors for Treatment of Isolated Oligohydramnios | Biotech Hunter | Biotech Hunter